All Compliance Week articles in Web Issue – Page 405
-
Event
Compliance Week 2018 – 13th Annual Conference
Mayflower Hotel1127 Connecticut Ave NWWashington, DC 20036-4301United States
-
Blog
Banks reconsider business approaches as CECL draws near
A pending new requirement for how to reflect loan losses in financial statements is beginning to affect how banks do business, according to a recent poll.
-
Podcast
Podcast: SAP on building a risk-aware corporate culture
In this edition of the Compliance Week podcast, we chat with Kevin McCollom of SAP SE, a market leader in enterprise application software. We discuss developing a risk-aware corporate culture amid an ever-evolving threat landscape, and the competitive advantages of compliance.
-
Blog
Wells Fargo charm offensive
New Wells Fargo ads in prominent business newspapers are an effort to let the world know the bank is cleaning up its act—but, without follow-through, it may not be enough.
-
Blog
ZTE and the Arthur Andersen myth
Remember the myth of Arthur Andersen—that if you go to trial in a corruption case and lose, the company will be irreparably harmed? That myth may have arisen once again in the form of a U.S. president criticizing U.S. regulators for penalizing Chinese company ZTE.
-
Blog
SEC names chief risk and strategy officer of the OCIE
The SEC has named James Reese as chief risk and strategy officer of the agency’s Office of Compliance Inspections and Examinations. Reese has served as acting chief since February 2017.
-
Article
Compliance considerations of Iran sanctions
President Trump’s recent decision to withdraw the U.S. from the Iran nuclear deal will not only have severe sanctions implications for foreign subsidiaries of U.S. parent companies, but will also negatively impact EU firms.
-
Blog
European Commission acts to preserve Iran Nuclear Deal
In response to U.S. President Donald Trump’s withdrawal of the United States from the Iran Nuclear Deal, the European Commission on May 18 announced steps to preserve the interests of European companies investing in Iran and to demonstrate the EU’s commitment to the deal.
-
Blog
FDA will publicly scold drug companies that try to derail generics
The FDA’s new tactic for driving down prescription drug costs: publicly shaming them by “shining a light on situations where drug makers may be pursuing gaming tactics to delay generic competition.” Drug companies that try to scuttle generic competition will be named on the FDA’s Website.
-
Blog
Report: Wells Fargo employees may have altered customer documents
The latest catalyst for bad news at Wells Fargo: allegations that employees altered information on business customers’ forms and documents.
-
Blog
System, identification issues complicate lease adoption
Companies are telling the SEC they are still having trouble getting IT systems in place that can put leases on corporate balance sheets as required in 2019.
-
Article
Report finds plenty of blame to go around in Carillion debacle
A report into what went wrong at collapsed construction giant Carillion reads like a masterclass in failed governance, assurance, and regulatory oversight.
-
Resource
Best Practices: Compliance Programs Now Require Microlearning
Traditional long compliance training sessions, whether in-person or online, are no longer effective. Employees get bored, tune out and disengage – shorter attention spans demand shorter bursts of content. Utilizing microlearning methods in your training ensures that employees will engage with and retain your compliance communications.
-
Blog
Chief compliance officer, two broker-dealers charged with AML offenses
The Securities and Exchange Commission on May 16 announced that it settled charges against broker-dealers Chardan Capital Markets and Industrial and Commercial Bank of China Financial Services for failing to report suspicious sales of billions of penny stock shares. Chardan’s chief compliance officer was also charged.
-
Blog
Novartis lawyer quits amid Michael Cohen contract controversy
Swiss pharmaceutical giant Novartis announced May 16 that Group General Counsel Felix Ehrat is stepping down. His abrupt departure follows revelations that Novartis had a $1.2 million contract with President Donald Trump’s personal attorney Michael Cohen in exchange for access to the White House on healthcare policy.
-
Podcast
Podcast: the risks and regulatory challenges of cryptocurrencies
Our latest podcast features Eric Sohn, a financial crime specialist and director of business product at Dow Jones Risk & Compliance, in a conversation about the fraud and money laundering risks raised by the fervor surrounding cryptocurrencies and Initial Coin Offerings.
-
Article
SEC: Forget ‘broken windows’ policy of the past
Moving away from a past focus on minor infractions, SEC Chairman Jay Clayton wants his enforcement division to buckle down on bigger matters.
-
Article
What to do to make sure you’re ready for GDPR
Data protection experts are emphatic about what a company’s first reaction should be if it believes it is not fully GDPR compliant as 25 May approaches: Don’t panic.
-
Article
Auditors plan deeper dives into outsource provider reports
As guidance changes and regulators continue to hammer on internal controls, auditors are starting to dig deeper into reports provided by outsourced service providers.
-
Article
Rabobank uses Latin to help with GDPR compliance
Jaclyn Jaeger talks with Peter Claassen of Rabobank about the bank’s collaboration with IBM to use cryptographic pseudonyms to anonymize customer information for GDPR compliance.